GENETIC DIAGNOSIS
NIMGenetics offers genomic solutions fitted for each Hospital, Clinical Laboratory or Genetic Service.
We supply our clients with the type of product that best meet their specific needs: form our disease-oriented platforms and designs (prenatal, constitutional, cancer, stem cells) until the final Diagnostic Service with bioinformatic analysis and clinical interpretation included.
KaryoNIM® Prenatal 15K.
Designed to detect the presence or absence of genetic and chromosome alterations responsible of the 96 most common genetic syndromes. Genetic power 10 to 50 times higher that normal G-banded karyotype.
For further information, please contact NIMGenetics.
KaryoNIM® Prenatal 60K.
A more potent version than the 15K, designed to detect the presence or absence of genetic and chromosome alterations responsible of the 127 most common genetic syndromes. Genetic power 50 to 100 times higher that normal G-banded karyotype.
For further information, please contact NIMGenetics.
KaryoNIM® Postnatal 60K.
Designed to detect the presence or absence of genetic and chromosome alterations responsible of the 160 most common genetic syndromes. It is optimized for postnatal genetic diagnosis. Genetic power 50 to 100 times higher that normal G-banded karyotype.
For further information, please contact NIMGenetics.
KaryoNIM® Postnatal 180K.
Microarray design that includes the possibility of detect Single Nucleotide Polymorphysms (known as SNPs). Our design allows to detect the presence or absence of genetic and chromosome alterations responsible of the 500 regions of the genome involved in the genetic diseases that are described and accepted by the ISCA Consortium. In addition, this microarray also may be used to detect genetic diseases that are generally caused by other type of mutations called Uniparental Dysomy (UPD) and that are blinded to the common array-CGH method.
For further information, please contact NIMGenetics.
KaryoNIM® Stem cells.
Microarray design (in a 60K format) optimized for the study of genetic and chromosome aberrations (aneuploidy, amplicons, deletions that may be present in cultured human stem cells to be used for cellular therapy. Our array allows to analyze, in every sample, the genomic status of more than 400 genes that have been related with cancer and cellular progression, including the 6 gene currently used in genetic manipulation of stem cells: U5F1, SOX2, NANOG, MYC, KLF4, LIN28.
For further information, please contact NIMGenetics.
OncoNIM-CD Cancer Diagnostics.
Designed on a 60K format, this array allows the study of genetic biomarkers (trisomies, monosomies, amplicons and deletions) related with the diagnosis of tumour samples and leukaemias. It includes 430 genes related with cancer. It is indicated and optmized to simultaneously study the chromosome aberrations of clinical use in the diagnosis of several types of cancer: bladder, melanoma (skin tumour), breast, lung, etc.
For further information, please contact NIMGenetics.
OncoNIM-CF Cancer Familiar.
60K microarray directed to improved the genetic diagnosis of familiar cancer patients. Our microarray is optimized to study and to detect the presence of mutations due to gross deletions that may affect to 30 genes related with hereditary tumours such as breast, colon, ovary and endocrine cancers.
For further information, please contact NIMGenetics.
